Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma.

J Hematol Oncol · 2013 · PMC3879031 · PMID 24305507

Europe PMC DOI

hedged sentence

0.0720

closest p · 1.4× alpha

0.0720

boldest claim

The sentences

did not reach statistical significancep = 0.072so close (0.05 < p ≤ 0.1)

Infiltrating human CD20+ cells were also reduced in the spleen of treated group (74 ± 35.6 per million of total cells) compared to the control group (261 ± 72.5 per million of total cells), although it did not reach statistical significance (p = 0.072).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.